GGrantIndex
Sort

40,608 grants matching prostate cancer

Phase III Study of Donepezil in the Irradiated Brain

$320,842
Stephen R Rapp · Wake Forest University Health Sciences · R01 · FY2010 · NR

DNA Damage-Response Defects in Prostate Cancer Risk

$320,798
Wanguo Liu · Lsu Health Sciences Center · R01 · FY2009 · CA

Integrin Signaling Pathways in Prostate Cancer

$320,790
Lucia R Languino · Thomas Jefferson University · R01 · FY2014 · CA

Enhancing cancer outreach for low-income adults with innovative smoking cessation

$320,785
Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

RIBONUCLEASES IN CANCER CHEMOTHERAPY

$320,772
University Of Wisconsin Madison · R01 · FY2004 · CA

Estrogen Receptors in Human Prostate Stem-Progenitor Cells

$320,752
Gail S Prins · University Of Illinois At Chicago · R01 · FY2014 · CA

Pragmatic Trial - Telehealth Research and Innovation for Veterans with Cancer (THRIVE).

$320,740
Danil V. Makarov · New York University School Of Medicine · P50 · FY2022 · CA

Mechanisms on metastasis and survival in alcoholic mice

$320,721
Gary G Meadows · Washington State University · R01 · FY2007 · AA

Mechanisms on metastasis and survival in alcoholic mice

$320,721
Gary G Meadows · Washington State University · R01 · FY2009 · AA

Mechanisms on metastasis and survival in alcoholic mice

$320,721
Gary G Meadows · Washington State University · R01 · FY2008 · AA

Development of Practical Mid-infrared Spectroscopic Imaging Technology for Cancer

$320,720
Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2012 · EB

A ROLE OF MASPIN IN PROSTATE CANCER

$320,709
Wayne State University · R01 · FY2004 · CA

Immune mediated mechanisms of metastasis

$320,700
Paola T Drapkin · Sanford Research/Usd · P20 · FY2019 · GM

Cost-Effectiveness of Prostate Cancer Screen/Treatment

$320,692
University Of Chicago · R01 · FY2001 · CA

Phase II Clincal Trial of Purified Isofavones in Prostate Cancer: Comparing Safet

$320,681
Nagi B Kumar · University Of South Florida · P20 · FY2012 · MD

Novel genomic mechanism for ligand-dependent transcription by androgen receptor

$320,681
Qianben Wang · Duke University · R01 · FY2018 · GM

Quantitative dual-energy CT imaging for radiation therapy treatment planning

$320,649
Jeffrey F Williamson · Virginia Commonwealth University · R01 · FY2012 · CA

Prostate cancer prevention by tocopherols

$320,637
Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2015 · CA

Socioeconomic status and smoking exposure in Appalachia

$320,627
Joshua E Muscat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · DA

Regulation and function of the YAP transcription co-activator oncoprotein

$320,588
Kun-Liang Guan · University Of California, San Diego · R01 · FY2008 · CA

External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence

$320,588
Pamela L Paris · University Of California, San Francisco · R01 · FY2012 · CA

Stromal AR Roles in Prostate Hyperplasia and Cancer

$320,588
Chawnshang Chang · University Of Rochester · R01 · FY2012 · CA

Androgen Receptor Function in Prostate Cancer

$320,588
Richard G Pestell · Thomas Jefferson University · R01 · FY2009 · CA

High Density Lipoprotein Nanoparticles for siRNA Delivery

$320,588
Colby Shad Thaxton · Northwestern University At Chicago · R01 · FY2016 · CA

High Density Lipoprotein Nanoparticles for siRNA Delivery

$320,588
Colby Shad Thaxton · Northwestern University At Chicago · R01 · FY2012 · CA